 | • レポートコード：MRC2-11QY11120 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は眼瞼炎のグローバル市場について調査・分析したレポートです。種類別（前眼瞼炎、後眼瞼炎、混合眼瞼炎）市場規模、用途別（病院、専門センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別眼瞼炎の競争状況、市場シェア ・世界の眼瞼炎市場：種類別市場規模 2015年-2020年（前眼瞼炎、後眼瞼炎、混合眼瞼炎） ・世界の眼瞼炎市場：種類別市場規模予測 2021年-2026年（前眼瞼炎、後眼瞼炎、混合眼瞼炎） ・世界の眼瞼炎市場：用途別市場規模 2015年-2020年（病院、専門センター） ・世界の眼瞼炎市場：用途別市場規模予測 2021年-2026年（病院、専門センター） ・北米の眼瞼炎市場分析：米国、カナダ ・ヨーロッパの眼瞼炎市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの眼瞼炎市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の眼瞼炎市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの眼瞼炎市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Merck、Gelderma、Novartis、Lux Biosciences、InSite Vision Incorporated、Foamix、LABORATORIES THEA、Kala Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Blepharitis is a chronic condition that is caused by chronic inflammation of the eyelid. It is a common eye disorder that is caused either by bacterial infection or skin condition (dandruff on scalp or acne rosacea). This is not a contagious disease condition and generally does not cause a permanent damage to the eye. Blepharitis is a common eye condition that leads the eyelid to redden, swollen and appears scaly at the base of the eye lashes. A dysfunction of the oil glands in eye lid due to hormone imbalance leads to blepharitis. Burning of the eye, sensitivity to light, blurred vision, dry eyes and crusting of eyelashes are some of the common symptoms observed in the patient suffering from blepharitis.
The global blepharitis market is majorly driven by rising prevalence of ophthalmological disorders, such as dry eye, uveitis among others. Additionally, factors such as government initiatives, rising demand for advanced treatment, increasing awareness among mass regarding eye care, and growing market players offering newer products for the treatment of blepharitis are likely to drive the market. Similarly, the involvement of leading players in new product development and upgrading their existing products to boost their product portfolio is boosting the growth of global blepharitis market.
Market Analysis and Insights: Global Blepharitis Market
The global Blepharitis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Blepharitis Scope and Market Size
Blepharitis market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Blepharitis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Merck
Gelderma
Novartis
Lux Biosciences
InSite Vision Incorporated
Foamix
LABORATORIES THEA
Kala Pharmaceuticals
Market segment by Type, the product can be split into
Anterior Blepharitis
Posterior Blepharitis
Mixed Blepharitis
Market segment by Application, split into
Hospitals
Specialty Centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Blepharitis Revenue
1.4 Market by Type
1.4.1 Global Blepharitis Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Anterior Blepharitis
1.4.3 Posterior Blepharitis
1.4.4 Mixed Blepharitis
1.5 Market by Application
1.5.1 Global Blepharitis Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Specialty Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Blepharitis Market Perspective (2015-2026)
2.2 Global Blepharitis Growth Trends by Regions
2.2.1 Blepharitis Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Blepharitis Historic Market Share by Regions (2015-2020)
2.2.3 Blepharitis Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Blepharitis Market Growth Strategy
2.3.6 Primary Interviews with Key Blepharitis Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Blepharitis Players by Market Size
3.1.1 Global Top Blepharitis Players by Revenue (2015-2020)
3.1.2 Global Blepharitis Revenue Market Share by Players (2015-2020)
3.1.3 Global Blepharitis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Blepharitis Market Concentration Ratio
3.2.1 Global Blepharitis Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Blepharitis Revenue in 2019
3.3 Blepharitis Key Players Head office and Area Served
3.4 Key Players Blepharitis Product Solution and Service
3.5 Date of Enter into Blepharitis Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Blepharitis Historic Market Size by Type (2015-2020)
4.2 Global Blepharitis Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Blepharitis Market Size by Application (2015-2020)
5.2 Global Blepharitis Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Blepharitis Market Size (2015-2020)
6.2 Blepharitis Key Players in North America (2019-2020)
6.3 North America Blepharitis Market Size by Type (2015-2020)
6.4 North America Blepharitis Market Size by Application (2015-2020)
7 Europe
7.1 Europe Blepharitis Market Size (2015-2020)
7.2 Blepharitis Key Players in Europe (2019-2020)
7.3 Europe Blepharitis Market Size by Type (2015-2020)
7.4 Europe Blepharitis Market Size by Application (2015-2020)
8 China
8.1 China Blepharitis Market Size (2015-2020)
8.2 Blepharitis Key Players in China (2019-2020)
8.3 China Blepharitis Market Size by Type (2015-2020)
8.4 China Blepharitis Market Size by Application (2015-2020)
9 Japan
9.1 Japan Blepharitis Market Size (2015-2020)
9.2 Blepharitis Key Players in Japan (2019-2020)
9.3 Japan Blepharitis Market Size by Type (2015-2020)
9.4 Japan Blepharitis Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Blepharitis Market Size (2015-2020)
10.2 Blepharitis Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Blepharitis Market Size by Type (2015-2020)
10.4 Southeast Asia Blepharitis Market Size by Application (2015-2020)
11 India
11.1 India Blepharitis Market Size (2015-2020)
11.2 Blepharitis Key Players in India (2019-2020)
11.3 India Blepharitis Market Size by Type (2015-2020)
11.4 India Blepharitis Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Blepharitis Market Size (2015-2020)
12.2 Blepharitis Key Players in Central & South America (2019-2020)
12.3 Central & South America Blepharitis Market Size by Type (2015-2020)
12.4 Central & South America Blepharitis Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Merck
13.1.1 Merck Company Details
13.1.2 Merck Business Overview
13.1.3 Merck Blepharitis Introduction
13.1.4 Merck Revenue in Blepharitis Business (2015-2020))
13.1.5 Merck Recent Development
13.2 Gelderma
13.2.1 Gelderma Company Details
13.2.2 Gelderma Business Overview
13.2.3 Gelderma Blepharitis Introduction
13.2.4 Gelderma Revenue in Blepharitis Business (2015-2020)
13.2.5 Gelderma Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview
13.3.3 Novartis Blepharitis Introduction
13.3.4 Novartis Revenue in Blepharitis Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 Lux Biosciences
13.4.1 Lux Biosciences Company Details
13.4.2 Lux Biosciences Business Overview
13.4.3 Lux Biosciences Blepharitis Introduction
13.4.4 Lux Biosciences Revenue in Blepharitis Business (2015-2020)
13.4.5 Lux Biosciences Recent Development
13.5 InSite Vision Incorporated
13.5.1 InSite Vision Incorporated Company Details
13.5.2 InSite Vision Incorporated Business Overview
13.5.3 InSite Vision Incorporated Blepharitis Introduction
13.5.4 InSite Vision Incorporated Revenue in Blepharitis Business (2015-2020)
13.5.5 InSite Vision Incorporated Recent Development
13.6 Foamix
13.6.1 Foamix Company Details
13.6.2 Foamix Business Overview
13.6.3 Foamix Blepharitis Introduction
13.6.4 Foamix Revenue in Blepharitis Business (2015-2020)
13.6.5 Foamix Recent Development
13.7 LABORATORIES THEA
13.7.1 LABORATORIES THEA Company Details
13.7.2 LABORATORIES THEA Business Overview
13.7.3 LABORATORIES THEA Blepharitis Introduction
13.7.4 LABORATORIES THEA Revenue in Blepharitis Business (2015-2020)
13.7.5 LABORATORIES THEA Recent Development
13.8 Kala Pharmaceuticals
13.8.1 Kala Pharmaceuticals Company Details
13.8.2 Kala Pharmaceuticals Business Overview
13.8.3 Kala Pharmaceuticals Blepharitis Introduction
13.8.4 Kala Pharmaceuticals Revenue in Blepharitis Business (2015-2020)
13.8.5 Kala Pharmaceuticals Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Blepharitis Key Market Segments
Table 2. Key Players Covered: Ranking by Blepharitis Revenue
Table 3. Ranking of Global Top Blepharitis Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Blepharitis Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Anterior Blepharitis
Table 6. Key Players of Posterior Blepharitis
Table 7. Key Players of Mixed Blepharitis
Table 8. Global Blepharitis Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Blepharitis Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Blepharitis Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Blepharitis Market Share by Regions (2015-2020)
Table 12. Global Blepharitis Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Blepharitis Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Blepharitis Market Growth Strategy
Table 18. Main Points Interviewed from Key Blepharitis Players
Table 19. Global Blepharitis Revenue by Players (2015-2020) (Million US$)
Table 20. Global Blepharitis Market Share by Players (2015-2020)
Table 21. Global Top Blepharitis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Blepharitis as of 2019)
Table 22. Global Blepharitis by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Blepharitis Product Solution and Service
Table 25. Date of Enter into Blepharitis Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Blepharitis Market Size by Type (2015-2020) (Million US$)
Table 28. Global Blepharitis Market Size Share by Type (2015-2020)
Table 29. Global Blepharitis Revenue Market Share by Type (2021-2026)
Table 30. Global Blepharitis Market Size Share by Application (2015-2020)
Table 31. Global Blepharitis Market Size by Application (2015-2020) (Million US$)
Table 32. Global Blepharitis Market Size Share by Application (2021-2026)
Table 33. North America Key Players Blepharitis Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Blepharitis Market Share (2019-2020)
Table 35. North America Blepharitis Market Size by Type (2015-2020) (Million US$)
Table 36. North America Blepharitis Market Share by Type (2015-2020)
Table 37. North America Blepharitis Market Size by Application (2015-2020) (Million US$)
Table 38. North America Blepharitis Market Share by Application (2015-2020)
Table 39. Europe Key Players Blepharitis Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Blepharitis Market Share (2019-2020)
Table 41. Europe Blepharitis Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Blepharitis Market Share by Type (2015-2020)
Table 43. Europe Blepharitis Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Blepharitis Market Share by Application (2015-2020)
Table 45. China Key Players Blepharitis Revenue (2019-2020) (Million US$)
Table 46. China Key Players Blepharitis Market Share (2019-2020)
Table 47. China Blepharitis Market Size by Type (2015-2020) (Million US$)
Table 48. China Blepharitis Market Share by Type (2015-2020)
Table 49. China Blepharitis Market Size by Application (2015-2020) (Million US$)
Table 50. China Blepharitis Market Share by Application (2015-2020)
Table 51. Japan Key Players Blepharitis Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Blepharitis Market Share (2019-2020)
Table 53. Japan Blepharitis Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Blepharitis Market Share by Type (2015-2020)
Table 55. Japan Blepharitis Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Blepharitis Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Blepharitis Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Blepharitis Market Share (2019-2020)
Table 59. Southeast Asia Blepharitis Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Blepharitis Market Share by Type (2015-2020)
Table 61. Southeast Asia Blepharitis Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Blepharitis Market Share by Application (2015-2020)
Table 63. India Key Players Blepharitis Revenue (2019-2020) (Million US$)
Table 64. India Key Players Blepharitis Market Share (2019-2020)
Table 65. India Blepharitis Market Size by Type (2015-2020) (Million US$)
Table 66. India Blepharitis Market Share by Type (2015-2020)
Table 67. India Blepharitis Market Size by Application (2015-2020) (Million US$)
Table 68. India Blepharitis Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Blepharitis Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Blepharitis Market Share (2019-2020)
Table 71. Central & South America Blepharitis Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Blepharitis Market Share by Type (2015-2020)
Table 73. Central & South America Blepharitis Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Blepharitis Market Share by Application (2015-2020)
Table 75. Merck Company Details
Table 76. Merck Business Overview
Table 77. Merck Product
Table 78. Merck Revenue in Blepharitis Business (2015-2020) (Million US$)
Table 79. Merck Recent Development
Table 80. Gelderma Company Details
Table 81. Gelderma Business Overview
Table 82. Gelderma Product
Table 83. Gelderma Revenue in Blepharitis Business (2015-2020) (Million US$)
Table 84. Gelderma Recent Development
Table 85. Novartis Company Details
Table 86. Novartis Business Overview
Table 87. Novartis Product
Table 88. Novartis Revenue in Blepharitis Business (2015-2020) (Million US$)
Table 89. Novartis Recent Development
Table 90. Lux Biosciences Company Details
Table 91. Lux Biosciences Business Overview
Table 92. Lux Biosciences Product
Table 93. Lux Biosciences Revenue in Blepharitis Business (2015-2020) (Million US$)
Table 94. Lux Biosciences Recent Development
Table 95. InSite Vision Incorporated Company Details
Table 96. InSite Vision Incorporated Business Overview
Table 97. InSite Vision Incorporated Product
Table 98. InSite Vision Incorporated Revenue in Blepharitis Business (2015-2020) (Million US$)
Table 99. InSite Vision Incorporated Recent Development
Table 100. Foamix Company Details
Table 101. Foamix Business Overview
Table 102. Foamix Product
Table 103. Foamix Revenue in Blepharitis Business (2015-2020) (Million US$)
Table 104. Foamix Recent Development
Table 105. LABORATORIES THEA Company Details
Table 106. LABORATORIES THEA Business Overview
Table 107. LABORATORIES THEA Product
Table 108. LABORATORIES THEA Revenue in Blepharitis Business (2015-2020) (Million US$)
Table 109. LABORATORIES THEA Recent Development
Table 110. Kala Pharmaceuticals Business Overview
Table 111. Kala Pharmaceuticals Product
Table 112. Kala Pharmaceuticals Company Details
Table 113. Kala Pharmaceuticals Revenue in Blepharitis Business (2015-2020) (Million US$)
Table 114. Kala Pharmaceuticals Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Blepharitis Market Share by Type: 2020 VS 2026
Figure 2. Anterior Blepharitis Features
Figure 3. Posterior Blepharitis Features
Figure 4. Mixed Blepharitis Features
Figure 5. Global Blepharitis Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Specialty Centers Case Studies
Figure 8. Blepharitis Report Years Considered
Figure 9. Global Blepharitis Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Blepharitis Market Share by Regions: 2020 VS 2026
Figure 11. Global Blepharitis Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Blepharitis Market Share by Players in 2019
Figure 14. Global Top Blepharitis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Blepharitis as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Blepharitis Revenue in 2019
Figure 16. North America Blepharitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Blepharitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Blepharitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Blepharitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Blepharitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Blepharitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Blepharitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
直接前方アプローチの世界市場（～2026年） Osteoarthritis is one of the prime reasons for aggravating hip pain in the elderly. Direct anterior approach (DAA) is a minimally invasive surgery made possible with a small incision without cutting any tendons. This technique has benefits such as low surgery time, reduced post-surgery pain, and rap…- 直接前股関節置換術の世界市場（～2026年） A hip replacement is an invasive surgical procedure, used to remove a diseased or fractured hip joint and replace it with an artificial joint or prosthesis. Osteoarthritis is one of the most common factors for hip diseases. Structures within the hip (such as the cartilage or bony joint surfaces) may…
- 前部ブドウ膜炎の世界市場（～2026年） Anterior uveitis is an inflammation of the middle layer of the eye. This layer includes the iris (colored part of the eye) and the adjacent tissue, known as the ciliary body. Geographically, the global anterior uveitis market is studied under five main regions namely North America, Latin America, As…
- アナログ・ミックスドシグナルIPの世界市場（～2026年） Increasing technological focus and investments from market leaders in this region are driving this market, making it the the largest market for AMS IP. The growing number of players in the North American region have resulted in increasing collaboration, which leads to growing technology. Europe is t…
- 強膜炎の世界市場（～2026年） Sclera is the outer layer of the eye. Scleritis is a disorder in which the sclera severely becomes red and inflamed. Globally North America is the largest market for Scleritis. Europe is the second-largest market and Asia Pacific is expected to grow at a rapid rate. Market Analysis and Insights: Glo…